Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin
Titel:
Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin
Auteur:
Hladunewich, Michelle A. Cattran, Dan Sethi, Sanjeev M. Hayek, Salim S. Li, Jing Wei, Changli Mullin, Sarah I. Reich, Heather N. Reiser, Jochen Fervenza, Fernando C.